Inventor
MAIKO HAMADA
Inventor
JP
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07KPeptides9%
PatentTitleYear
12,102,641Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereof202411,890,288Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereof202411,802,135Lysophosphatidic acid derivative202311,542,273Amide compound having bet proteolysis-inducing action and medicinal application thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2024Patents assigned to MITSUBISHI TANABE PHARMA CORP (4)· patent assignee history
2023Patents assigned to UNIV OSAKA (1)· patent assignee history
2023–2024Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MITSUBISHI TANABE PHARMA CORP | 4 | 2023–2024 |
| UNIV OSAKA | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 4 | 2023–2024 |